海印股份(000861.SZ)遭深交所公開譴責記入上市公司誠信檔案
格隆匯8月20日丨海印股份(000861.SZ)公佈,公司於2019年8月20日收到深交所出具的《關於對廣東海印集團股份有限公司及相關當事人給予紀律處分的公告》。深交所對公司給予公開譴責的處分;對董事長邵建明,董事兼總裁邵建佳,董事、副總裁兼董事會祕書潘尉給予公開譴責的處分;對董事兼副總裁陳文勝,獨立董事李峻峯、朱為繹、慕麗娜給予通報批評的處分。同時,深交所將上述處分記入上市公司誠信檔案。
原因為:2019年6月12日,公司披露《關於簽署〈合作合同〉的公告》,擬與許啟太、海南今珠農業發展有限公司合作投資用於防治非洲豬瘟的今珠多糖注射液產品,但上述合作公告披露的相關信息存在不真實、不準確、不完整的問題。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.